Position
Fidelity in Adc Therapeutics Sa
Back to the book · All holders of ADCT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$355.8K$3.75 → $1.07
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 133.8K | $472.3K | — | — | — | 0.0% |
| Q1 2026 | 172.7K | $647.5K | $3.75 | $29.4K | $145.8K | 0.0% |
| Q2 2026 | 132.8K | $142.1K | $1.07 | −$355.8K | −$149.6K | 0.0% |